Fed-Batch
31 Results
Advanced Search
Showing
-
-
Cellvento CHO Cell Culture Media and Feeds | Biopharmaceutical Manufacturing | Merck
With the introduction of Cellvento CHO media and Cellvento Feed products, Merck offers you chemically defined, non-animal origin media formulations for batch and fed-batch mode operations. -
Press Release: Merck Launches Cellvento™ CHO-200 Chemically Defined Cell Culture Medium for Consistent High Performance in Fed-Batch Mode
Merck, today launched Cellvento™ CHO-200 chemically defined cell culture medium, a product of non-animal origin that delivers robust cell growth and consistent high performance. -
Life Science Webinars - Merck
Browse our webinar library to watch and learn advanced research techniques, valuable tips and advice from leaders in their fields of scientific research. -
Assessment of Needs | Clarification Learning Center | Biopharmaceutical Manufacturing | Merck
Assessing your needs is critical to obtaining the correct solution. Two areas to consider are: defining your process and determining the success criteria. -
Perfusion-Based Approaches for Upstream Intensification | Merck
BioContinuum™ Production & Harvest Platform: freeze down time with perfusion-based approaches for upstream intensification. -
M Lab ™ Collaboration Centers | Biopharmaceutical Manufacturing | Merck
We have built M Lab™ Collaboration Centers, a place where you can collaborate with experts to solve the challenges you face every day in your biopharma and pharma facilities. From Upstream to Downstream and through Final Fill, our non-GMP facilities are resource hubs for you to explore, learn and collaborate -
Event | Upstream Technical Symposium | Merck
Merck and LFB Biomanufacturing invite you to the Upstream Technical Symposium. -
Continuous Bioprocessing for mAbs: Market Trends | Merck
Continuous bioprocessing: important drivers and market trends to take into consideration for the adoption of intensified processing. -
Press Release: Merck to Supply Single-use Systems to WuXi Biologics for Non-GMP Pilot Plant in Shanghai
Merck was selected by contract development and manufacturing organization WuXi Biologics to provide Merck's Mobius® single-use systems and technologies to fully equip a non-GMP pilot plant in Shanghai, China.